Skip to main content
Log in

Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Background

Helicobacter pylori infection and hyperplastic polyp are known to have strong connections, but there are not enough randomized controlled trial data.

Aims

To evaluate the effect of H. pylori eradication on gastric hyperplastic polyp.

Method

This is an open-labeled, single-center, randomized controlled trial. Patients with hyperplastic polyp and current infection of H. pylori were randomly assigned to eradication or non-eradication groups. All participants underwent follow-up endoscopy to investigate the regression of gastric polyps. Gastric polyp regression was defined as the disappearance of polyps or a reduction of more than 50% in size.

Results

Thirty-two patients were randomized to eradication (n = 17) and non-eradication groups (n = 15). Final included patients were 14 in eradication group and 13 in non-eradication group. All patients showed polyp regression in eradication group, whereas no regression was observed in non-eradication group (P < 0.001). Disappearance of polyp (n = 7) and decrease in size (n = 7) were observed in eradication group. In non-eradication group, no change (n = 5), increase of size (n = 5), and increase of number (n = 3) were observed. Mean regression time was 6.8 months, and disappearance time was 9.8 months. In non-eradication group, hyperglycemia was noted in 50% of progression group but not noted in no change group (P = 0.057).

Conclusions

H. pylori eradication induced regression of hyperplastic polyp, and persistent H. pylori infection was related to progression of gastric polyp.

Clinical Trial Registration

ClinicalTrials.gov ID: NCT03065868

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Nam SY, Park BJ, Ryu KH, et al. Effect of Helicobacter pylori infection and its eradication on the fate of gastric polyps. Eur J Gastroenterol Hepatol. 2016;28:449–454.

    PubMed  Google Scholar 

  2. Daibo M, Itabashi M, Hirota T. Malignant transformation of gastric hyperplastic polyps. Am J Gastroenterol. 1987;82:1016–1025.

    CAS  PubMed  Google Scholar 

  3. Orlowska J, Pietrow D. Multifocal gastric carcinoma arising from hyperplastic and adenomatous polyps. Am J Gastroenterol. 1990;85:1629–1634.

    CAS  PubMed  Google Scholar 

  4. Orlowska J, Jarosz D, Pachlewski J, et al. Malignant transformation of benign epithelial gastric polyps. Am J Gastroenterol. 1995;90:2152–2159.

    CAS  PubMed  Google Scholar 

  5. Cristallini EG, Ascani S, Bolis GB. Association between histologic type of polyp and carcinoma in the stomach. Gastrointest Endosc. 1992;38:481–484.

    CAS  PubMed  Google Scholar 

  6. Ginsberg GG, Al-Kawas FH, Fleischer DE, et al. Gastric polyps: relationship of size and histology to cancer risk. Am J Gastroenterol. 1996;91:714–717.

    CAS  PubMed  Google Scholar 

  7. Suzuki S, Ohkusa T, Shimoi K, et al. Disappearance of multiple hyperplastic polyps after the eradication of Helicobacter pylori. Gastrointest Endosc. 1997;46:566–568.

    CAS  PubMed  Google Scholar 

  8. Ohkusa T, Miwa H, Hojo M, et al. Endoscopic, histological and serologic findings of gastric hyperplastic polyps after eradication of Helicobacter pylori: comparison between responder and non-responder cases. Digestion. 2003;68:57–62.

    PubMed  Google Scholar 

  9. Nam SY, Park BJ, Ryu KH, et al. Effect of helicobacter pylori eradication on the regression of gastric polyps in national cancer screening program. Korean J Intern Med. 2018;33:506–511.

    PubMed  Google Scholar 

  10. Goddard AF, Badreldin R, Pritchard DM, et al. The management of gastric polyps. Gut. 2010;59:1270–1276.

    PubMed  Google Scholar 

  11. Ji F, Wang ZW, Ning JW, et al. Effect of drug treatment on hyperplastic gastric polyps infected with Helicobacter pylori: a randomized, controlled trial. World J Gastroenterol. 2006;12:1770–1773.

    PubMed  PubMed Central  Google Scholar 

  12. Carmack SW, Genta RM, Schuler CM, et al. The current spectrum of gastric polyps: a 1-year national study of over 120,000 patients. Am J Gastroenterol. 2009;104:1524–1532.

    PubMed  Google Scholar 

  13. Shaib YH, Rugge M, Graham DY, et al. Management of gastric polyps: an endoscopy-based approach. Clin Gastroenterol Hepatol. 2013;11:1374–1384.

    PubMed  PubMed Central  Google Scholar 

  14. Ohkusa T, Takashimizu I, Fujiki K, et al. Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. Ann Intern Med. 1998;129:712–715.

    CAS  PubMed  Google Scholar 

  15. Nam SY, Park BJ, Nam JH, et al. Association of current Helicobacter pylori infection and metabolic factors with gastric cancer in 35,519 subjects: a cross-sectional study. United Eur Gastroenterol J. 2019;7:287–296.

    Google Scholar 

  16. Crawley DJ, Holmberg L, Melvin JC, et al. Serum glucose and risk of cancer: a meta-analysis. BMC Cancer. 2014;14:985.

    PubMed  PubMed Central  Google Scholar 

  17. Yu F, Guo Y, Wang H, et al. Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies. BMC Cancer. 2016;16:642.

    PubMed  PubMed Central  Google Scholar 

  18. Jung YS, Park CH, Park JH, et al. Efficacy of Helicobacter pylori eradication therapies in Korea: a systematic review and network meta-analysis. Helicobacter. 2017;22:e12389.

    Google Scholar 

  19. Choi KS, Jun JK, Suh M, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: results of the National Cancer Screening Programme in Korea. Br J Cancer. 2015;112:608–612.

    CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by a grand from Korean Colleague of Helicobacter and Upper Gastrointestinal Research (2015), Korea.

Author information

Authors and Affiliations

Authors

Contributions

SY Nam contributed to the study design. SY Nam, SY Lee, SW Jeon, YH Kwon, and HS Lee contributed to the acquisition of data, implementation and supervision of the study. SY Nam and SW Lee contributed to the assembly of data. SY Nam and SW Lee analyzed the data. SY Nam took the responsibility for the accuracy of the data analysis and had full access to the data in the study. All authors participated in the writing of the manuscript and approved the final version of the manuscript.

Corresponding author

Correspondence to Su Youn Nam.

Ethics declarations

Conflict of interest

All authors declare that they have no potential conflicts including financial interests, activities, relationships, and affiliations.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary smaterial.

Supplementary material 1 (DOCX 16 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nam, S.Y., Lee, S.W., Jeon, S.W. et al. Helicobacter pylori Eradication Regressed Gastric Hyperplastic Polyp: A Randomized Controlled Trial. Dig Dis Sci 65, 3652–3659 (2020). https://doi.org/10.1007/s10620-020-06065-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-020-06065-0

Keywords

Navigation